[Chemotherapeutic results in chronic pyelonephritis with a combination of trimethoprim with sulfamethoxazole (Eusaprim)].
D062365:Aminobenzoates / Q000096:biosynthesis; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004357:Drug Synergism; D004927:Escherichia coli Infections / Q000188:drug therapy; D005492:Folic Acid / Q000096:biosynthesis; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D011512:Proteus Infections / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*
D062365:Aminobenzoates; D000900:Anti-Bacterial Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D005492:Folic Acid; D013420:Sulfamethoxazole
Chemotherapieergebnisse bei chronischer Pyelonephritis mit einer Kombination von Trimethoprim mit Sulfamethoxazol (Eusaprim)